CTOs on the Move

Healthcare Partners Investments

www.hpillc.org

 
Healthcare Partners Investments is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.hpillc.org
  • 14024 Quail Pointe Dr
    Oklahoma City, OK USA 73134
  • Phone: 405.419.8484

Executives

Name Title Contact Details

Similar Companies

St Charles Parish Hospital

St Charles Parish Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Luling, LA. To find more information about St Charles Parish Hospital, please visit www.stch.net

Genesis HealthCare System

Genesis HealthCare System was created in 1997 as an affiliation between Bethesda Care System and Good Samaritan Medical Center — two health care organizations that had served the community for more than 100 years each. We are a not-for-profit organization that operates two hospital sites — Genesis-Bethesda and Genesis-Good Samaritan — in Zanesville, Ohio, and several affiliated health care organizations. By combining the resources of the two organizations, we have been able to provide several new services for the community, including open-heart surgery, a Level II neonatal intermediate care unit and enhanced cancer services. Our primary service area is a six-county region of southeastern Ohio, including Muskingum, Morgan, Perry, Coshocton, Noble and Guernsey counties.

Medigraphics Corporation

Medigraphics Corporation is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Jenson Medical International

Jenson Medical International is a Conroe, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

InnFocus

InnFocus, Inc., an early stage company pioneering a microsurgical solution for glaucoma.InnFocus is an ophthalmology company founded in 2003 with extensive biomaterials experience that develops and provides next generation products for glaucoma surgery. Glaucoma is a disease for which there is no cure, is the second leading cause of blindness in the world and afflicts an estimated 60 million people worldwide.